Akhtar Muhammad, Karimi Hossein, Gilani Syed Amir, Ahmad Ashfaq, Raza Asim
University of Lahore, Lahore, Pakistan.
BMC Musculoskelet Disord. 2020 Nov 21;21(1):770. doi: 10.1186/s12891-020-03787-0.
The objective of the study was to compare the effects of neuromobilization (NM) techniques and routine physiotherapy on pain and functional disability in patients having shoulder impingement syndrome (SIS). Present study was aimed to discover evidence based conservative and cost effective remedy on pain and functional disability.
Single blinded randomized control clinical trial.
A total of 80 patients with SIS were randomly assigned into care and experimental groups (40 in each group). After the baseline assessment routine physiotherapy was executed on both groups, while NM was applied additionally to experimental group. Pain and functional disability score were evaluated by Visual Analogue Scale and University of California at Los Angeles rating score at baseline, 5th and 11th week. Differences in outcome between groups were evaluated with clinical improvement.
The experimental group compared with care group at 11th week had lower mean pain score 2.15(1.66-2.64) vs 4.90(4.41-5.40); between group difference, 1.82; 95% (CI), - 2.38 to - 1.25; P < 0.001 and Partial ƞ = 0.33, similarly functional disability score 28.58(27.32-29.83) vs 20.10(18.84-21.36); between group difference,5.62; 95%CI, (4.32-6.92); P< 0.001 and Partial ƞ = 0.49 respectively. In experimental group NM was a more effective technique to reduce the pain severity and disability in SIS patients as compare to care group.
Neuromobilization techniques in addition to routine physiotherapy were significantly effective for the treatment of SIS.
IRCT20190121042445N1 , Registered 19 February 2019.
本研究的目的是比较神经松动术(NM)和常规物理治疗对肩峰撞击综合征(SIS)患者疼痛和功能障碍的影响。本研究旨在发现基于证据的保守且具有成本效益的疼痛和功能障碍治疗方法。
单盲随机对照临床试验。
总共80例SIS患者被随机分为对照组和试验组(每组40例)。在基线评估后,两组均进行常规物理治疗,而试验组额外应用神经松动术。在基线、第5周和第11周时,通过视觉模拟量表和加州大学洛杉矶分校评分对疼痛和功能障碍评分进行评估。通过临床改善情况评估两组间结果的差异。
试验组在第11周时与对照组相比,平均疼痛评分更低,分别为2.15(1.66 - 2.64)和4.90(4.41 - 5.40);组间差异为1.82;95%(CI),-2.38至-1.25;P < 0.001,偏ƞ = 0.33,同样,功能障碍评分分别为28.58(27.32 - 29.83)和20.10(18.84 - 21.36);组间差异为5.62;95%CI,(4.32 - 6.92);P < 0.001,偏ƞ = 0.49。与对照组相比,在试验组中神经松动术是一种更有效的减轻SIS患者疼痛严重程度和功能障碍的技术。
除常规物理治疗外,神经松动术对SIS的治疗具有显著效果。
IRCT20190121042445N1,于2019年2月19日注册。